首页 | 本学科首页   官方微博 | 高级检索  
     

大剂量阿糖胞苷治疗儿童白血病不良反应
引用本文:储金华,谢志伟. 大剂量阿糖胞苷治疗儿童白血病不良反应[J]. 安徽医学, 2011, 32(1): 38-40. DOI: 10.3969/j.issn.1000-0399.2011.01.015
作者姓名:储金华  谢志伟
作者单位:安徽医科大学第二附属医院儿科,合肥,230601;安徽医科大学第二附属医院儿科,合肥,230601
摘    要:目的总结采用以大剂量阿糖胞苷(Ara-C)为主的联合化疗方案对儿童急性白血病进行治疗的不良反应、防治措施及效果。方法 45例初诊急性白血病患儿诱导治疗达到完全缓解(CR)后予以大剂量Ara-C为主的联合巩固化疗(每次Ara-C 2.0 g/m2),观察90例次治疗中出现的不良反应及防治效果。结果所有患儿均出现明显骨髓抑制,且部分患儿出现相关感染,但对症支持治疗后获缓解;药物热、皮疹、口腔炎和结膜炎也是常见的不良反应;肝脏、肾脏、心脏及神经毒性少见。结论在大剂量Ara-C治疗过程中采用积极有效的综合防治措施,能够使患儿安全完成巩固诱导治疗。

关 键 词:白血病  大剂量阿糖胞苷  毒副作用  支持治疗

Dealing with the adverse effects in treating children with acute leukemia with high dose of cyto arabinose
Chu Jinhua,Xie Zhiwei. Dealing with the adverse effects in treating children with acute leukemia with high dose of cyto arabinose[J]. Anhui Medical Journal, 2011, 32(1): 38-40. DOI: 10.3969/j.issn.1000-0399.2011.01.015
Authors:Chu Jinhua  Xie Zhiwei
Affiliation:Chu Jinhua,Xie Zhiwei Department of Pediatrics,the Second Affiliated Hospital of Anhui Medical University,Hefei 230601,China
Abstract:Objective In order to understand the adverse effects of the intensive consolidation induction chemotherapy with high dose cytarabine(HDAra-C) as the main drug to treat children with acute leukemia and the results of the comprehensive prevention measures to deal with such adverse effects.Methods 45 children with acute leukemia received this intensive combined chemotherapy with HDAraC as the main drug when they reached complete remission(CR) with the induction therapy(HDAraC 2.0g/m2).90 cases were sampled for...
Keywords:Leukemia  High dose cytarabine  Side effect  Supportive treatment  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号